TheProfitWatch

ANTX - AN2 Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.15 -0.06 (-5.22%) --- 0.0 (0.0%) 0.0 (-0.46%) 0.0 (0.0%) 0.03 (2.83%) --- 0.0 (0.0%)

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.21
Diluted EPS:
-0.21
Basic P/E:
-5.1905
Diluted P/E:
-5.1905
RSI(14) 1m:
0.0
VWAP:
1.09
RVol:

Events

Period Kind Movement Occurred At

Related News